FDA’s Electronic Premarket Submissions Pilot Program

by | Oct 26, 2020 | FDA, Medical Devices, Quality, Regulatory

The US FDA’s Center for Devices and Radiological Health (CDRH) announced a new pilot program that will allow the industry to submit premarket submissions electronically during the COVID-19 health emergency.1

The Electronic Delivery of Premarket Submissions Pilot Program’s objective is to test CDRH’s capabilities to receive pre-market submissions using BOX, which is a cloud-based sharing service. CDRH began accepting participants for this pilot on October 6th,2020 and the program is intended to last 90 days during the COVID-19 pandemic.1

The following is the eligibility criteria apply to enter the pilot program:1

  • Companies who intend to submit an e-copy of a premarket submission within 2 weeks of acceptance into the pilot program.
  • Can download and work with Box to upload files.
  • Follow the required procedures for participants

CDRH has the right to withdraw the application of the participant if it finds that a participant is ineligible.

If you would like to participate in the program, you can submit a statement of interest to  CDRH-Premarket-Submission-eDelivery-Support@fda.hhs.gov and include your statement of agreement to comply with the eligibility criteria listed above, a description of the premarket submission you intend on submitting within 2 weeks, and information on the size of your organization such as the number of employees and your revenue per year.1

CDRH will select up to 25 applicants that will include a broad spectrum of applicant types such as consultants that represent applicants. Enrollment will be ongoing throughout the pilot program.1

EMMA International will be happy to represent your application if you wish to participate in this pilot program. Call us today at +1 248-987-4497 or email us at info@emmainternatiional.com to learn more about how we can help.

1FDA (Oct 2020) Electronic Delivery of Premarket Submissions Pilot retrieved on 10/22/2020 from https://www.fda.gov/medical-devices/how-study-and-market-your-device/electronic-delivery-premarket-submissions-pilot


Nikita Angane

Nikita Angane

Solutions Delivery Specialist - Ms. Angane is a Bioengineering graduate with experience in medical device commercialization, product development, quality system compliance and regulatory affairs. Her portfolio includes working on medical devices, combination products, and pharmaceuticals. As a Solutions Delivery Specialist at EMMA International, she offers her expertise to help our clients achieve an effective and sustainable quality system, and develop regulatory strategies for market access and compliance of new products in the US and international markets. Ms. Angane earned a Bachelor of Engineering in Biomedical Engineering from the University of Mumbai, India and an M.S. in Bioengineering from University of Illinois at Chicago.

More Resources

Change Management And Control

Change Management And Control

One of the biggest and most important aspects of quality management is a system to monitor changes and how they impact the product. Change management is an approach for changing processes or products in a way which adheres to regulatory standards by ensuring stability and consistency throughout processes. It applies across all changes within a process and throughout an entire products life cycle.
Aseptic Technique and Gowning

Aseptic Technique and Gowning

One of the most common techniques to prevent contamination of products and reduce quality impacts in the pharmaceutical industry is called aseptic gowning. Humans are the biggest sources of microbial contamination in cleanroom environments and therefore proper gowning procedures are essential to ensuring product quality. Proper training, education, hygiene, qualification, and authorization must be put in place and be required for entry to all clean room environments...
Importance of Pharmaceutical GMP

Importance of Pharmaceutical GMP

Having high quality standards is vital to any organization but is even more essential in the pharmaceutical industry. Practices that are governed by these standards are commonly called Good Manufacturing Practices (GMP) and ensure consistent and controlled production of products. These practices govern all aspects and procedures within production and provide documented proof that procedures are consistently followed during the manufacturing processes every time products are made. They are designed to minimize risks throughout the manufacturing process that are not able to be eliminated in final product testing so that pharmaceuticals are safe for use...

Ready to learn more about working with us?

Pin It on Pinterest

Share This